Skip to main content
Livermore
Livermore
ZHEN

Parallel Advisors, LLC

SEC CIK
0001690010
Latest filing
Aug 5, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Parallel Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
5,389
Value
$2.68M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of VRTX by Parallel Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,389$2.68M<0.1%−133−2.4%ReducedHolders
Q1 20265,522$2.47M<0.1%+333+6.4%AddedHolders
Q4 20255,189$2.35M<0.1%+134+2.7%AddedHolders
Q3 20255,055$1.98M<0.1%−211−4.0%ReducedHolders
Q2 20255,266$2.34M<0.1%−184−3.4%ReducedHolders
Q1 20255,450$2.64M0.1%−1,885−25.7%ReducedHolders
Q4 20247,335$2.95M0.1%+143+2.0%AddedHolders
Q3 20247,192$3.34M0.1%+820+12.9%AddedHolders
Q2 20246,372$2.99M0.1%+863+15.7%AddedHolders
Q1 20245,509$2.30M0.1%+733+15.3%AddedHolders
Q4 20234,776$1.94M0.1%+1,309+37.8%AddedHolders
Q3 20233,467$1.21M<0.1%+242+7.5%AddedHolders
Q2 20233,225$1.13M<0.1%+177+5.8%AddedHolders
Q1 20233,048$960.3K<0.1%+843+38.2%AddedHolders
Q4 20222,205$636.8K<0.1%+22+1.0%AddedHolders
Q3 20222,183$632.0K<0.1%+159+7.9%AddedHolders
Q2 20222,024$570.0K<0.1%+71+3.6%AddedHolders
Q1 20221,953$501.0K<0.1%+101+5.5%AddedHolders
Q4 20211,852$407.0K<0.1%+400+27.5%AddedHolders
Q3 20211,452$263.0K<0.1%+115+8.6%AddedHolders
Q2 20211,337$270.0K<0.1%+69+5.4%AddedHolders
Q1 20211,268$272.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.